retatrutide type 2 diabetes phase 2 trial 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 shows. is part of an emerging generation Lilly's triple agonist delivers up

Cultural attitudes toward obesity as a condition requiring pharmacological intervention also remain more conservative than in Western markets

As private healthcare infrastructure grows and multinational pharmaceutical companies increase their investments, accessibility is getting better

Unfortunately, our database did not include information regarding treatment duration, distribution of time from index date to treatment initiation, the percentage of covered time or whether both medications were taken concurrently in patients receiving combination therapy

But the "longevity gap" is closing, and while we may live longer, women often spend a greater portion of those later years in poor health compared to men